[A Case of Gastric Cancer with Continued Progression-Free Survival Even after Total Gastrectomy and Nivolumab Therapy].

Fujii, Haruka; Choda, Yasuhiro; Kubota, Tetsushi; Ishida, Michihiro; Sato, Daisuke; Sumitani, Daisuke; Yoshimitsu, Masanori; Nakano, Kanyu; Harano, Masao; Matsukawa, Hiroyoshi; Idani, Hitoshi; Shiozaki, Shigehiro; Okajima, Masazumi

Fujii, Haruka; Choda, Yasuhiro; Kubota, Tetsushi; Ishida, Michihiro; Sato, Daisuke; Sumitani, Daisuke; Yoshimitsu, Masanori; Nakano, Kanyu; Harano, Masao; Matsukawa, Hiroyoshi; Idani, Hitoshi; Shiozaki, Shigehiro; Okajima, Masazumi.

Affiliation

Fujii H; Dept. of Surgery, Hiroshima City Hiroshima Citizens Hospital.

Gan To Kagaku Ryoho ; 46(13): 2318-2320, 2019 Dec.

Article in Ja | MEDLINE | ID: mdl-32156917

Subject(s)

Antineoplastic Agents, Immunological/therapeutic use; Nivolumab/therapeutic use; Stomach Neoplasms; Aged; Female; Gastrectomy; Humans; Progression-Free Survival; Stomach Neoplasms/drug therapy; Stomach Neoplasms/surgery

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Agents, Immunological / Nivolumab Limits: Aged / Female / Humans Language: Ja Journal: Gan To Kagaku Ryoho Year: 2019 Type: Article

Search on Google

XML

PubMed Links